Indolent prostate cancer and active surveillance Sue Mayor 1 January 2010 Grandround 0 Number 34 Download pdf article Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article active surveillanceprostate cancer
News Metastatic prostate cancer: cabazitaxel shows quality of life benefits over both abiraterone and enzalutamide News 6 October 2020 0
Impact Factor For localised prostate cancer, does technology equal progress? Impact Factor 1 September 2012 0
Leave a Reply